Related content

Tumor markers for hepatocellular carcinoma (Review)

By      

Molecular and Clinical Oncology, Vol. 1, Iss. 4, 2013-01 ,pp. : 593-598

Spandidos Publications

Access to resources Recommend Favorite

Histological Assessment of Combined Chemoembolization and Alcohol Infusion for Hepatocellular Carcinoma in Cirrhotic Patients

By Troisi R.   Hesse U.   Pattyn P.   Praet M.   Defreyne L.   Elewaut A.   Berrevoet F.   De Hemptinne B.  

Transplantation Proceedings, Vol. 29, Iss. 5, 1997-08 ,pp. : 2412-2413

Elsevier

Access to resources Recommend Favorite

CYLD downregulation is correlated with tumor development in patients with hepatocellular carcinoma

By Kinoshita  

Molecular and Clinical Oncology, Vol. 1, Iss. 2, 2013-01 ,pp. : 309-314

Spandidos Publications

Access to resources Recommend Favorite

Living-donation liver transplantation for hepatocellular carcinoma: time to drop the limitations?

By Steinmuller T.   Pascher A.   Sauer I.M.   Theruvath T.   Muller A.R.   Settmacher U.   Neuhaus P.  

Transplantation Proceedings, Vol. 34, Iss. 6, 2002-09 ,pp. : 2263-2264

Elsevier

Access to resources Recommend Favorite

Local recurrence of hepatocellular carcinoma in the tumor blood drainage area following radiofrequency ablation

By                  

Molecular and Clinical Oncology, Vol. 2, Iss. 2, 2014-01 ,pp. : 182-186

Spandidos Publications

Access to resources Recommend Favorite